Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Pharma marketers: keeping abreast of new technologies

Murat Tanoren shares what he’s learned from his successes, and how pharma marketers can keep abreast of emerging technologies whilst remaining customer centric. Murat Tanoren works as the marketing manager at Boehringer Ingelheim in the disease areas of...

Articles

Is pharma serious about customer relationship management?

Kevin Dolgin compares the role of a sales rep in two constantly evolving areas: the financial industry and the pharmaceutical industry. Years ago, the job of a pharmaceutical sales representation was to visit doctors as much as possible. During the visit, the...

Articles

Pharma marketing 2.0 – have we M.E.T yet?

Carrie L Carrier discusses the top three essential qualities that all pharma companies must have in order to achieve marketing excellence. Much has been written about pharmaceutical marketing's reluctance to fully embrace the new technologies taking...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital